[Present state and future view of the indications for H. pyloni eradication therapy].
Takahashi
Shin'ichi
S
The Third Department of Internal Medicine, Kyorin University School of Medicine.
Tanaka
Akifumi
A
Sugano
Hajime
H
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D005757:Gastritis, Atrophic / Q000209:etiology / Q000628:therapy; D005764:Gastroesophageal Reflux; D016481:Helicobacter Infections / Q000150:complications* / Q000188:drug therapy; D016480:Helicobacter pylori; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000209:etiology / Q000628:therapy; D010437:Peptic Ulcer / Q000209:etiology / Q000628:therapy; D013274:Stomach Neoplasms / Q000209:etiology / Q000628:therapy
D000894:Anti-Inflammatory Agents, Non-Steroidal